1. Home
  2. VIOT vs KPTI Comparison

VIOT vs KPTI Comparison

Compare VIOT & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VIOT

Viomi Technology Co. Ltd

HOLD

Current Price

$1.42

Market Cap

151.6M

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$6.29

Market Cap

148.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIOT
KPTI
Founded
2014
2008
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.6M
148.0M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
VIOT
KPTI
Price
$1.42
$6.29
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$22.17
AVG Volume (30 Days)
345.7K
431.6K
Earning Date
03-24-2026
02-12-2026
Dividend Yield
5.50%
N/A
EPS Growth
N/A
N/A
EPS
0.36
N/A
Revenue
$385,267,177.00
$142,530,000.00
Revenue This Year
$42.19
$3.55
Revenue Next Year
$0.96
N/A
P/E Ratio
$3.53
N/A
Revenue Growth
16.89
N/A
52 Week Low
$1.18
$3.51
52 Week High
$4.33
$10.38

Technical Indicators

Market Signals
Indicator
VIOT
KPTI
Relative Strength Index (RSI) 41.09 43.37
Support Level $1.30 $6.22
Resistance Level $1.42 $6.97
Average True Range (ATR) 0.09 0.57
MACD 0.04 -0.07
Stochastic Oscillator 93.10 29.06

Price Performance

Historical Comparison
VIOT
KPTI

About VIOT Viomi Technology Co. Ltd

Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: